Cargando…
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
β-hemoglobinopathies are the most common genetic disorders worldwide and are caused by mutations affecting the production or the structure of adult hemoglobin. Patients affected by these diseases suffer from anemia, impaired oxygen delivery to tissues, and multi-organ damage. In the absence of a com...
Autores principales: | Frati, Giacomo, Miccio, Annarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865242/ https://www.ncbi.nlm.nih.gov/pubmed/33525591 http://dx.doi.org/10.3390/jcm10030482 |
Ejemplares similares
-
Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
por: Fontana, Letizia, et al.
Publicado: (2023) -
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
por: Paschoudi, Kiriaki, et al.
Publicado: (2023) -
Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
por: Miccio, Annarita, et al.
Publicado: (2022) -
β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies
por: Barbarani, Gloria, et al.
Publicado: (2020) -
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)